Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02349308 · ClinicalTrials.gov registry record
Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter
A clinical trial, sponsored by Merit Medical Systems.
- Completed
- Registry status
- 10
- Enrollment target
NCT02349308: Completed study, sponsored by Merit Medical Systems.
NCT02349308 is a clinical trial that has completed, run by Merit Medical Systems. The registered enrollment target is 10 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02349308 has completed, sponsored by Merit Medical Systems.
- COMPLETED
- Registry status
- 10 participants
- Enrollment target
Study Summary
The purpose of this study is to demonstrate the stability of blood flow with the CentrosFLO catheter, during intermittent dialysis over a period of 6 months after placement.
Primary Outcome
Stability of hydraulic resistance measured as normalized arterial pressure in mmHg/mL/min by dialysis flow meter weekly for up to six months
Interventions
- DEVICE CentrosFLO Long Term Hemodialysis Catheter
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-07 |
What the finished NCT02349308 record still lists
NCT02349308 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 10 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which CentrosFLO Long Term Hemodialysis Catheter is the first listed.
NCT02349308 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02349308 about?
NCT02349308 is a clinical study titled "Post Marketing Surveillance of the CentrosFLO™ Tunneled IJ Catheter". The purpose of this study is to demonstrate the stability of blood flow with the CentrosFLO catheter, during intermittent dialysis over a period of 6 months after placement.
What is the current status of trial NCT02349308?
This trial is currently completed. The enrollment target is 10 participants. The study started on 2013-10. Estimated completion is 2015-07.
What interventions are being tested in trial NCT02349308?
The interventions under investigation include: CentrosFLO Long Term Hemodialysis Catheter (DEVICE).
Who is sponsoring clinical trial NCT02349308?
This trial is sponsored by Merit Medical Systems, which has 18 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00623389 · 10 participants · NA
Evaluation of an Advanced Lower Extremity Neuroprostheses
- NCT01241864 · 10 participants · Phase 2
Islet Transplantation in Type 1 Diabetic Kidney Allograft
- NCT01293214 · 10 participants · NA
Vascularized Composite Allotransplantation for Multiple Extremity Amputations
- NCT01474148 · 10 participants · NA
A Neuroprosthesis for Seated Posture and Balance
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia